Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LFX453 in External Genital Warts
NCT02482428Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LFX453 in condyloma acuminatum, sponsored by Novartis. Started May 2015; status: completed.
02
Drugs
LFX453
03
Conditions
condyloma acuminatum
Beyond the preview
Go deeper on NCT02482428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482428.